<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03611881</url>
  </required_header>
  <id_info>
    <org_study_id>2018P000539/PHS</org_study_id>
    <nct_id>NCT03611881</nct_id>
  </id_info>
  <brief_title>Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)</brief_title>
  <acronym>ScreenASSIST</acronym>
  <official_title>Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized controlled trial seeks to evaluate the effectiveness of alternative
      strategies to integrate smoking cessation interventions into the delivery of low-dose CT
      (LDCT) lung cancer screening. Using a factorial design, current smokers who enroll will be
      randomly assigned to receive these interventions: (1) smoking cessation counseling support by
      telephone or videoconferencing (short duration vs. long duration); (2) nicotine patch
      treatment (NRT) (short vs.long duration); (3) counselor-facilitated referral (vs. no
      referral) to an online resource to connect smokers to a community-based social service
      resources.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Evidence-based tobacco dependence treatment consists of behavioral counseling and
      pharmacotherapy. Nicotine patch is an FDA-approved cessation aid. The optimal duration of
      counseling and pharmacotherapy for patients undergoing low-dose CT (LDCT) lung screening is
      not clear. In addition, helping smokers to address other social and psychological barriers
      might help them succeed in quitting smoking. This randomized controlled trial will test, in a
      factorial design, two options for delivering each of 3 interventions to help current smokers
      stop smoking in the context of having routine CT lung cancer screening. Patients will receive
      4 or 8 weeks of behavioral counseling (with their choice of video conferencing or regular
      telephone calls), 2 or 8 weeks of nicotine patch, and will receive referral (vs. no referral)
      to an online resource to connect smokers to community-based social service resources. Outcome
      measures for smoking cessation will be assessed by a survey administered by phone at 3,and 6
      months. Patients who self-report 7-day abstinence at 3- and 6- months follow-up will be asked
      to provide a saliva sample to assay for cotinine.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 8, 2019</start_date>
  <completion_date type="Anticipated">February 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biochemically-verified past 7-day abstinence from cigarette smoking</measure>
    <time_frame>6 Months</time_frame>
    <description>Patient report of no cigarettes smoked in the past 7 days (point prevalence abstinence), confirmed biochemically by saliva cotinine &lt;=10 ng/ml or expired air carbon monoxide (CO) &lt;10 ppm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Self-reported past 7-day smoking abstinence</measure>
    <time_frame>3 months after enrollment</time_frame>
    <description>Patient self-report of no cigarettes smoked in the past 7 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported past 7-day smoking abstinence</measure>
    <time_frame>6 months after enrollment</time_frame>
    <description>Patient self-report of no cigarette smoking in the past 7 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with &gt;50% reduction in cigarettes smoked per day</measure>
    <time_frame>3 Months</time_frame>
    <description>&gt;50% decrease in cigarettes smoked per day between baseline and follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with &gt;50% reduction in cigarettes smoked per day</measure>
    <time_frame>6 months</time_frame>
    <description>&gt;50% decrease in cigarettes smoked per day between baseline and follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who make an intentional attempt to quit smoking</measure>
    <time_frame>3 months</time_frame>
    <description>Intentional attempt to quit smoking cigarettes that lasts for &gt;=24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biochemically-verified past 7-day abstinence from cigarette smoking</measure>
    <time_frame>3 Months</time_frame>
    <description>Patient report of no cigarettes smoked in the past 7 days (point prevalence abstinence), confirmed biochemically by saliva cotinine &lt;=10 ng/ml or expired air carbon monoxide (CO) &lt;10 ppm.</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">720</enrollment>
  <condition>Smoking, Tobacco</condition>
  <arm_group>
    <arm_group_label>Short, Short, Present</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 weeks of counseling (by phone or videoconferencing) + 2 weeks of nicotine patch + referral to community resource.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Short, Long, Present</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 weeks of counseling (by phone or videoconferencing) + 8 weeks of nicotine patch + referral to community resource.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long, Short, Present</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 weeks of counseling (by phone or videoconferencing) + 2 weeks of nicotine patch + referral to community resource.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long, Long, Present</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 weeks of counseling (by phone or videoconferencing) + 8 weeks of nicotine patch + referral to community resource.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Short, Short, Absent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 weeks of counseling (by phone or videoconferencing) + 2 weeks of nicotine patch + no referral to community resource.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Short, Long, Absent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 weeks of counseling (by phone or videoconferencing) + 8 weeks of nicotine patch + no referral to community resource.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long, Short, Absent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 weeks of counseling (by phone or videoconferencing) + 2 weeks of nicotine patch + no referral to community resource.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long, Long, Absent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 weeks of counseling (by phone or videoconferencing) + 8 weeks of nicotine patch + no referral to community resource.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Counseling</intervention_name>
    <description>4 or 8 weeks of behavioral counseling support to promote smoking cessation.</description>
    <arm_group_label>Long, Long, Absent</arm_group_label>
    <arm_group_label>Long, Long, Present</arm_group_label>
    <arm_group_label>Long, Short, Absent</arm_group_label>
    <arm_group_label>Long, Short, Present</arm_group_label>
    <arm_group_label>Short, Long, Absent</arm_group_label>
    <arm_group_label>Short, Long, Present</arm_group_label>
    <arm_group_label>Short, Short, Absent</arm_group_label>
    <arm_group_label>Short, Short, Present</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine patch</intervention_name>
    <description>2 or 8 weeks of nicotine patch given in a tapering dose of 21 mg, 14 mg, 7 mg.</description>
    <arm_group_label>Long, Long, Absent</arm_group_label>
    <arm_group_label>Long, Long, Present</arm_group_label>
    <arm_group_label>Long, Short, Absent</arm_group_label>
    <arm_group_label>Long, Short, Present</arm_group_label>
    <arm_group_label>Short, Long, Absent</arm_group_label>
    <arm_group_label>Short, Long, Present</arm_group_label>
    <arm_group_label>Short, Short, Absent</arm_group_label>
    <arm_group_label>Short, Short, Present</arm_group_label>
    <other_name>NRT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Community Resource</intervention_name>
    <description>Counselor-facilitated referral to a community-based program to address social needs.</description>
    <arm_group_label>Long, Long, Present</arm_group_label>
    <arm_group_label>Long, Short, Present</arm_group_label>
    <arm_group_label>Short, Long, Present</arm_group_label>
    <arm_group_label>Short, Short, Present</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled to undergo LDCT-LCS at a participating Partners Health Care System LCS site

          -  Speak English or Spanish.

          -  Current smokers: smoked a cigarette, even a puff, in the last 30 days.

          -  Medicare coverage requirement (age 55-80 years, 30+ pack/years).

          -  Residing within the USA.

        Exclusion Criteria:

          -  Undergoing lung CT as part of a diagnostic or abnormal follow-up evaluation.

          -  Unable to give informed consent due to psychiatric or cognitive impairment as
             determined in consultation with study PI or treating clinician.

          -  No access to a telephone or cannot communicate by telephone.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elyse R Park, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nancy A Rigotti, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jennifer Haas, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elyse R Park, Ph.D.</last_name>
    <phone>(617) 724-6836</phone>
    <email>epark@mgh.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saif Hawari, MB, BCh, BAO</last_name>
    <phone>(617) 726-3261</phone>
    <email>shawari@mgh.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elyse R Park, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jennifer Haas, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>July 27, 2018</study_first_submitted>
  <study_first_submitted_qc>July 27, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2018</study_first_posted>
  <last_update_submitted>May 5, 2020</last_update_submitted>
  <last_update_submitted_qc>May 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Elyse Park, PhD</investigator_full_name>
    <investigator_title>Associate Professor of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>lung screening</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

